Fondation Fournier-Majoie

Foundation date

17/01/2007

Sector

#Investor

Subsector

Our mission is to provide support, from the initiation stage, to entrepreneurs personally committed to promoting innovative projects, aimed at delivering improvements in the health and welfare of human beings, thereby encouraging initial or ongoing entrepreneurship through innovation and team building. In this way the Foundation intends to contribute to medical and pharmaceutical progress, in accordance with professional and medical ethical rules.

Upcoming events

Latest news

  • argenx reports topline results from ADVANCE-SC study of VYVGART Hytrulo in primary immune thrombocytopenia

    20 hours ago

  • Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion

    Wednesday November 22nd 2023

  • argenx announces European Commission approval of subcutaneous VYVGART® (efgartigimod alfa) for generalized myasthenia gravis

    Thursday November 16th 2023